BITRF
Price:
$0.0145
Market Cap:
$19.84M
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.[Read more]
Industry
Biotechnology
IPO Date
2013-03-22
Stock Exchange
PNK
Ticker
BITRF
According to Biotron Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 19.46M. This represents a change of -73.28% compared to the average of 72.82M of the last 4 quarters.
The mean historical Enterprise Value of Biotron Limited over the last ten years is 29.00M. The current 19.46M Enterprise Value has changed 6.61% with respect to the historical average. Over the past ten years (40 quarters), BITRF's Enterprise Value was at its highest in in the December 2023 quarter at 81.68M. The Enterprise Value was at its lowest in in the June 2017 quarter at 7.09M.
Average
29.00M
Median
32.04M
Minimum
7.82M
Maximum
48.64M
Discovering the peaks and valleys of Biotron Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 283.37%
Maximum Annual Enterprise Value = 48.64M
Minimum Annual Increase = -70.71%
Minimum Annual Enterprise Value = 7.82M
Year | Enterprise Value | Change |
---|---|---|
2024 | 48.64M | 164.01% |
2023 | 18.42M | -56.84% |
2022 | 42.69M | 49.04% |
2021 | 28.64M | -19.16% |
2020 | 35.43M | -2.46% |
2019 | 36.33M | 283.37% |
2018 | 9.48M | 21.17% |
2017 | 7.82M | -70.71% |
2016 | 26.70M | -25.60% |
2015 | 35.88M | 30.74% |
The current Enterprise Value of Biotron Limited (BITRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
36.59M
5-year avg
34.77M
10-year avg
29.00M
Biotron Limited’s Enterprise Value is less than Bioasis Technologies Inc. (39.54M), less than Covalon Technologies Ltd. (85.75M), greater than Mosaic ImmunoEngineering Inc. (6.48M), greater than Ceapro Inc. (15.91M), less than Cellectis S.A. (144.28M), greater than Resverlogix Corp. (17.80M), less than Small Pharma Inc. (39.53M), less than Advanced Proteome Therapeutics Corporation (0), greater than ChitogenX Inc. (147.52K), greater than null (4.72M),
Company | Enterprise Value | Market cap |
---|---|---|
39.54M | $28.44M | |
85.75M | $67.67M | |
6.48M | $5.43M | |
15.91M | $13.31M | |
144.28M | $183.12M | |
17.80M | $11.12M | |
39.53M | $37.51M | |
0 | $147.52K | |
147.52K | $432.27K | |
4.72M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biotron Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biotron Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biotron Limited's Enterprise Value?
What is the highest Enterprise Value for Biotron Limited (BITRF)?
What is the 3-year average Enterprise Value for Biotron Limited (BITRF)?
What is the 5-year average Enterprise Value for Biotron Limited (BITRF)?
How does the current Enterprise Value for Biotron Limited (BITRF) compare to its historical average?